CHRISTOPHER LEHMAN: Open Payments
NPI 1376258020 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,500 in 30 payments from 8 companies in 2025. Trend: 2023 $587 · 2024 $2,866 · 2025 $3,500
Speaker / faculty: $3,000Food & beverage: $440Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $3,088 |
| Teva Pharmaceuticals USA, Inc. | 5 | $141 |
| Lundbeck LLC | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $60 |
| Neurocrine BioSciences, Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: VRAYLAR, REXULTI, AUSTEDO XR, INGREZZA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, CAPLYTA, UZEDY.
Industry payments across OH — which companies pay providers there.
